Study to Evaluate the Efficacy and Safety of SYSA1901 vs. Perjeta® of HER2-Positive Breast Cancer
Clinical trial NCT05720026 · UNKNOWN
Trial details
- NCT number
- NCT05720026
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-09
- Primary completion
- 2025-08-29
- Enrollment
- 560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.